Unknown

Dataset Information

0

Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative.


ABSTRACT: Introduction:We characterize long-term disease dynamics from cognitively healthy to dementia using data from the Alzheimer's Disease Neuroimaging Initiative. Methods:We apply a latent time joint mixed-effects model to 16 cognitive, functional, biomarker, and imaging outcomes in Alzheimer's Disease Neuroimaging Initiative. Markov chain Monte Carlo methods are used for estimation and inference. Results:We find good concordance between latent time and diagnosis. Change in amyloid positron emission tomography shows a moderate correlation with change in cerebrospinal fluid tau (? = 0.310) and phosphorylated tau (? = 0.294) and weaker correlation with amyloid-? 42 (? = 0.176). In comparison to amyloid positron emission tomography, change in volumetric magnetic resonance imaging summaries is more strongly correlated with cognitive measures (e.g., ? = 0.731 for ventricles and Alzheimer's Disease Assessment Scale). The average disease trends are consistent with the amyloid cascade hypothesis. Discussion:The latent time joint mixed-effects model can (1) uncover long-term disease trends; (2) estimate the sequence of pathological abnormalities; and (3) provide subject-specific prognostic estimates of the time until onset of symptoms.

SUBMITTER: Li D 

PROVIDER: S-EPMC6234901 | biostudies-other | 2018

REPOSITORIES: biostudies-other

altmetric image

Publications

Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative.

Li Dan D   Iddi Samuel S   Thompson Wesley K WK   Rafii Michael S MS   Aisen Paul S PS   Donohue Michael C MC  

Alzheimer's & dementia (Amsterdam, Netherlands) 20180829


<h4>Introduction</h4>We characterize long-term disease dynamics from cognitively healthy to dementia using data from the Alzheimer's Disease Neuroimaging Initiative.<h4>Methods</h4>We apply a latent time joint mixed-effects model to 16 cognitive, functional, biomarker, and imaging outcomes in Alzheimer's Disease Neuroimaging Initiative. Markov chain Monte Carlo methods are used for estimation and inference.<h4>Results</h4>We find good concordance between latent time and diagnosis. Change in amyl  ...[more]

Similar Datasets

| S-EPMC2376747 | biostudies-literature
| S-EPMC7928167 | biostudies-literature
| S-EPMC7549074 | biostudies-literature
| S-EPMC4049432 | biostudies-literature
| S-EPMC2809036 | biostudies-literature
| S-EPMC4718583 | biostudies-literature
| S-EPMC3555054 | biostudies-literature
| S-EPMC7481955 | biostudies-literature
| S-EPMC5081632 | biostudies-literature
| S-EPMC10825672 | biostudies-literature